Having completed more than 252 clinical trials across multiple aspects of neuroscience in the past five years, we have the hands-on experience and the seasoned experts to anticipate and overcome the obstacles.
Guiding you to a successful outcome
We understand the methodologies relevant to neurological indications and the critical success factors specific to each.
Our work touches more than 42,000 patients afflicted by all major central nervous system disorders.
Thought leaders in neuroscience drug development
We have the institutional knowledge to deal with a wide range of complex neurological indications.